規制薬物の世界市場レポート 2025年

規制薬物の市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）7.8％で1,365億1,000万米ドルに成長します。予測期間の成長は、精密医療、遠隔医療と遠隔ヘルスケア、オピオイド代替薬、継続的な規制の更新、メンタルヘルスへの関心の高まりに起因すると考えられます。予測期間の主な動向には、規制の変更とコンプライアンス、医薬品の安全性と乱用防止への関心の高まり、ドラッグデリバリー技術の進歩、バイオシミラーとジェネリック医薬品の登場、デジタルヘルスソリューションの統合などが含まれます。

医療用処方薬に対する需要の高まりは、今後の規制薬物市場の成長を後押しすると予想されます。処方薬は、病気の治療、治癒、改善、治療介入、予防を目的としたもので、多くの場合、規制薬物に分類されます。これらの医薬品は、患者の転帰を改善し、不必要な支出を削減することで、規制薬物市場に利益をもたらします。例えば、2024年9月、米国の連邦政府機関であるメディケアメディケイドサービスセンター（CMS）の報告によると、処方薬への支出は2021年の6.8％増に対し、2022年は8.4％増の4,059億米ドルに達しました。このように、医療用処方薬の需要拡大が規制薬物市場の拡大を牽引しています。

慢性疾患の増加は、規制薬物市場の成長を促進すると予測されています。慢性疾患は長期にわたって持続し、時間とともに悪化する傾向があります。規制対象物質は、疼痛管理、神経精神疾患、自己免疫疾患、心血管疾患、炎症性疾患などの慢性疾患に伴う症状の管理に役立っています。例えば、2023年1月に国立医学図書館が発表した統計では、2050年までに少なくとも1つの慢性疾患を持つ米国の50歳以上の人口は99.5％増加し、1億4,266万人に達すると予測されています。さらに、2022年9月に発表された世界保健機関（WHO）の2022年ハイライトによると、世界の死亡者数の74％（年間4,100万人）が非感染性疾患（NCDs）または慢性疾患に起因しています。したがって、慢性疾患の蔓延が規制薬物市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の規制薬物市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の規制薬物市場：成長率分析
• 世界の規制薬物市場の実績：規模と成長、2019～2024年
• 世界の規制薬物市場の予測：規模と成長、2024～2029年、2034年
• 世界の規制薬物総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の規制薬物市場：薬物別、実績と予測、2019～2024年、2024～2029年、2034年
• オピオイド
• 覚せい剤
• 鎮静剤
• カンナビノイド
• 世界の規制薬物市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の規制薬物市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 疼痛管理
• 睡眠障害
• うつ病と不安
• 発作
• 注意欠陥多動性障害（ADHD）
• その他
• 世界の規制薬物市場：オピオイドのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 天然オピオイド
• 半合成オピオイド
• 合成オピオイド
• 世界の規制薬物市場：覚せい剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• アンフェタミン
• メチルフェニデート
• コカイン
• 世界の規制薬物市場：鎮静剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ベンゾジアゼピン
• バルビツール酸
• 睡眠薬
• 世界の規制薬物市場：カンナビノイドのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• THC（テトラヒドロカンナビノール）
• CBD（カンナビジオール）
• 合成カンナビノイド

第7章 地域別・国別分析

• 世界の規制薬物市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の規制薬物市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 規制薬物市場：競合情勢
• 規制薬物市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Orbis Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GW Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis
  • Corium Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Aradigm Corporation
• Alkermes plc
• Sun Pharmaceutical Ltd.
• F. Hoffmann-La Roche Ltd.
• AbbVie Inc.
• Ampac Fine Chemicals
• Siegfried Holding AG
• Pfizer Inc.
• Novartis AG
• GlaxoSmithKline plc
• Sanofi S.A.
• Bristol-Myers Squibb
• Eli Lilly and Company
• AstraZeneca
• Teva Pharmaceutical Industries

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 規制薬物市場2029年：新たな機会を提供する国
• 規制薬物市場2029年：新たな機会を提供するセグメント
• 規制薬物市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A controlled substance is a drug or chemical, encompassing both illicit substances and legally prescribed pharmaceuticals, whose production, possession, or usage is regulated by the government. Controlled substance medications, whether prescribed legally or involved in illicit use, have restrictions due to their potential for causing physical and mental dependence. Despite the associated risks, these medications play a crucial role in alleviating pain and managing various symptoms, thereby enhancing the quality of life for individuals.

The primary types of controlled substances and drugs include opioids, stimulants, depressants, and cannabinoids. Opioids, for example, constitute a class of drugs utilized for the treatment of moderate to severe pain. They can be either synthesized in laboratories or derived from the opium poppy plant. These substances are distributed through various channels, including hospital pharmacies, retail pharmacies, and online platforms. Their applications span pain management, treatment for sleep disorders, addressing depression and anxiety, managing seizures, handling attention deficit hyperactivity disorder (ADHD), and more.

The controlled substances market research report is one of a series of new reports from The Business Research Company that provides controlled substances market statistics, including controlled substances industry global market size, regional shares, competitors with a controlled substances market share, detailed controlled substances market segments, market trends and opportunities, and any further data you may need to thrive in the controlled substances industry. The controlled substances market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The controlled substance market size has grown strongly in recent years. It will grow from $94.86 billion in 2024 to $101.15 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to medical advancements, regulatory frameworks, rising incidence of chronic diseases, expanding pharmaceutical industry, international trade, and collaboration.

The controlled substance market size is expected to see strong growth in the next few years. It will grow to $136.51 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to precision medicine, telemedicine and remote healthcare, opioid alternatives, continued regulatory updates, increased mental health focus. Major trends in the forecast period include regulatory changes and compliance, increasing focus on drug safety and abuse prevention, advancements in drug delivery technologies, emergence of biosimilars and generic versions, integration of digital health solution.

The rising demand for medically prescribed drugs is anticipated to boost the growth of the controlled substance market in the future. Prescription drugs are intended for the treatment, cure, remediation, therapeutic intervention, or prevention of illness, and they are often classified as controlled substances. These drugs benefit the controlled substance market by improving patient outcomes and reducing unnecessary spending. For example, in September 2024, a report from the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, indicated that spending on prescription drugs rose by 8.4% in 2022, reaching $405.9 billion, compared to a 6.8% increase in 2021. Thus, the growing demand for medically prescribed drugs is driving the expansion of the controlled substance market.

The increasing prevalence of chronic diseases is anticipated to fuel the growth of the controlled substance market. Chronic diseases persist over an extended period and tend to worsen with time. Controlled substances are instrumental in managing symptoms associated with chronic conditions such as pain management, neuropsychiatric disorders, autoimmune ailments, cardiovascular issues, and inflammatory disorders. For instance, statistics from the National Library of Medicine in January 2023 forecast a 99.5% increase, reaching 142.66 million people aged 50 and above in the US with at least one chronic condition by 2050. Furthermore, as per the World Health Organization's (WHO) 2022 Highlights released in September 2022, 74% of global deaths, totaling 41 million annually, are attributed to noncommunicable diseases (NCDs) or chronic diseases. Hence, the mounting prevalence of chronic illnesses is a driving force behind the growth of the controlled substance market.

Product innovation stands out as a prominent trend gaining traction in the controlled substance market. Key players within this market are actively innovating new drugs and products to maintain their competitive edge. For instance, in January 2022, CMM (CareFlow Medicines Management Ltd.), a UK-based provider of medicine management solutions, collaborated with Modeus, a healthcare software provider based in Australia, to introduce the Controlled Drug Manager (CD Manager). This innovative platform for controlled drug management ensures the safe handling and monitoring of controlled drugs, including patient-owned medications. The newly launched CMM CD Manager, powered by Modeus, seamlessly integrates with CMM's medication management platform and other external systems. It's tailored for clinical staff and pharmacists in hospitals' pharmacy, wards, and theaters where controlled medications are stored. Through built-in reporting functionalities, CD Manager assists Controlled Drug Accountable Officers by monitoring controlled drug lifecycles within organizations and promptly addressing inconsistencies or potential diversions through automated alerts.

Major companies within the controlled substance market are driving innovation by introducing advanced technological products such as the e-module, aimed at securing a competitive advantage. The e-module stands as an online, interactive educational resource meticulously designed to ensure the appropriate availability of controlled substances for medical and scientific purposes. As an example, in September 2022, The International Narcotics Control Board (INCB), an independent treaty body based in Austria, unveiled the e-module. This initiative addresses barriers hindering the sufficient availability of essential narcotic and psychotropic substances crucial for medical treatments. The e-module offers self-paced training focused on estimating and evaluating controlled substances while covering the legal framework of drug control. It is available free of charge for government officials working within competent national authorities. Additionally, it's accessible in multiple languages including English, French, Portuguese, Russian, and Spanish, with translations provided in other languages as well.

In November 2023, Noramco, a US-based pharmaceutical manufacturing company, acquired Halo Pharmaceuticals for an undisclosed amount. This acquisition allows Noramco to broaden its service offerings by incorporating drug product formulation development, manufacturing, and packaging capabilities for its active pharmaceutical ingredient (API) customers. Halo Pharmaceuticals is also a US-based pharmaceutical manufacturing company that specializes in controlled substances.

Major companies operating in the controlled substance market include Merck & Co. Inc., Johnson and Johnson Services Inc., Orbis Biosciences Inc., GW Pharmaceuticals plc, Corium Inc., Aradigm Corporation, Alkermes plc, Sun Pharmaceutical Ltd., F. Hoffmann-La Roche Ltd., AbbVie Inc., Ampac Fine Chemicals, Siegfried Holding AG, Pfizer Inc., Novartis AG, GlaxoSmithKline plc, Sanofi S.A., Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Teva Pharmaceutical Industries, Viatris Inc., Boehringer Ingelheim, Gilead Sciences, Amgen, Regeneron Pharmaceuticals, Abbott Laboratories, Mallinckrodt Pharmaceuticals, Endo International, Catalent, Cambrex Corporation, Lonza Group, Indivior plc, Ipsen SA

North America was the largest region in the controlled substance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the controlled substance market report during the forecast period. The regions covered in the controlled substance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the controlled substance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The controlled substance market consists of sales of morphine, valium, ritalin, heroin, cannabis, diazepam, flunitrazepam, and ketamine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Controlled Substance Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on controlled substance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for controlled substance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The controlled substance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug: Opioids; Stimulant; Depressants; Cannabinoids
• 2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 3) By Application: Pain Management; Sleep Disorders; Depression And Anxiety; Seizure; Attention Deficit Hyperactivity Disorder (ADHD); Other Applications
• Subsegments:
• 1) By Opioids: Natural Opioids; Semi-Synthetic Opioids; Synthetic Opioids
• 2) By Stimulants: Amphetamines; Methylphenidate; Cocaine
• 3) By Depressants: Benzodiazepines; Barbiturates; Sleep Medications
• 4) By Cannabinoids: THC (Tetrahydrocannabinol); CBD (Cannabidiol); Synthetic Cannabinoids
• Companies Mentioned: Merck & Co. Inc.; Johnson and Johnson Services Inc.; Orbis Biosciences Inc.; GW Pharmaceuticals plc; Corium Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Controlled Substance Market Characteristics

3. Controlled Substance Market Trends And Strategies

4. Controlled Substance Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Controlled Substance Growth Analysis And Strategic Analysis Framework

• 5.1. Global Controlled Substance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Controlled Substance Market Growth Rate Analysis
• 5.4. Global Controlled Substance Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Controlled Substance Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Controlled Substance Total Addressable Market (TAM)

6. Controlled Substance Market Segmentation

• 6.1. Global Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Opioids
• Stimulant
• Depressants
• Cannabinoids
• 6.2. Global Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.3. Global Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Sleep Disorders
• Depression And Anxiety
• Seizure
• Attention Deficit Hyperactivity Disorder (ADHD)
• Other Applications
• 6.4. Global Controlled Substance Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Opioids
• Semi-Synthetic Opioids
• Synthetic Opioids
• 6.5. Global Controlled Substance Market, Sub-Segmentation Of Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amphetamines
• Methylphenidate
• Cocaine
• 6.6. Global Controlled Substance Market, Sub-Segmentation Of Depressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Benzodiazepines
• Barbiturates
• Sleep Medications
• 6.7. Global Controlled Substance Market, Sub-Segmentation Of Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• THC (Tetrahydrocannabinol)
• CBD (Cannabidiol)
• Synthetic Cannabinoids

7. Controlled Substance Market Regional And Country Analysis

• 7.1. Global Controlled Substance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Controlled Substance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Controlled Substance Market

• 8.1. Asia-Pacific Controlled Substance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Controlled Substance Market

• 9.1. China Controlled Substance Market Overview
• 9.2. China Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Controlled Substance Market

• 10.1. India Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Controlled Substance Market

• 11.1. Japan Controlled Substance Market Overview
• 11.2. Japan Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Controlled Substance Market

• 12.1. Australia Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Controlled Substance Market

• 13.1. Indonesia Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Controlled Substance Market

• 14.1. South Korea Controlled Substance Market Overview
• 14.2. South Korea Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Controlled Substance Market

• 15.1. Western Europe Controlled Substance Market Overview
• 15.2. Western Europe Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Controlled Substance Market

• 16.1. UK Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Controlled Substance Market

• 17.1. Germany Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Controlled Substance Market

• 18.1. France Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Controlled Substance Market

• 19.1. Italy Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Controlled Substance Market

• 20.1. Spain Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Controlled Substance Market

• 21.1. Eastern Europe Controlled Substance Market Overview
• 21.2. Eastern Europe Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Controlled Substance Market

• 22.1. Russia Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Controlled Substance Market

• 23.1. North America Controlled Substance Market Overview
• 23.2. North America Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Controlled Substance Market

• 24.1. USA Controlled Substance Market Overview
• 24.2. USA Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Controlled Substance Market

• 25.1. Canada Controlled Substance Market Overview
• 25.2. Canada Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Controlled Substance Market

• 26.1. South America Controlled Substance Market Overview
• 26.2. South America Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Controlled Substance Market

• 27.1. Brazil Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Controlled Substance Market

• 28.1. Middle East Controlled Substance Market Overview
• 28.2. Middle East Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Controlled Substance Market

• 29.1. Africa Controlled Substance Market Overview
• 29.2. Africa Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Controlled Substance Market Competitive Landscape And Company Profiles

• 30.1. Controlled Substance Market Competitive Landscape
• 30.2. Controlled Substance Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Orbis Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GW Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Corium Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Controlled Substance Market Other Major And Innovative Companies

• 31.1. Aradigm Corporation
• 31.2. Alkermes plc
• 31.3. Sun Pharmaceutical Ltd.
• 31.4. F. Hoffmann-La Roche Ltd.
• 31.5. AbbVie Inc.
• 31.6. Ampac Fine Chemicals
• 31.7. Siegfried Holding AG
• 31.8. Pfizer Inc.
• 31.9. Novartis AG
• 31.10. GlaxoSmithKline plc
• 31.11. Sanofi S.A.
• 31.12. Bristol-Myers Squibb
• 31.13. Eli Lilly and Company
• 31.14. AstraZeneca
• 31.15. Teva Pharmaceutical Industries

32. Global Controlled Substance Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Controlled Substance Market

34. Recent Developments In The Controlled Substance Market

35. Controlled Substance Market High Potential Countries, Segments and Strategies

• 35.1 Controlled Substance Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Controlled Substance Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Controlled Substance Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer